NCT00002041View on ClinicalTrials.gov

Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Candidiasis, EsophagealHIV Infections
Interventions
DRUG

Amphotericin B

Trial Locations (1)

085434000

Bristol - Myers Squibb Co, Princeton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00002041 - Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients | Biotech Hunter | Biotech Hunter